TY - JOUR
T1 - Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative
T2 - myPPMI
AU - the Parkinson's Progression Markers Initiative
AU - Stanley, Craig E.
AU - Fabrizio, Kimberly
AU - McMahon, Bridget A.
AU - Matthews-McGee, Auldyn
AU - Fitzgerald, Cailey
AU - Singh, Zeina
AU - Rigby, Nichole H.
AU - Talarico, John Michael
AU - Brown, Ethan G.
AU - Korell, Monica
AU - McGuire Kuhl, Maggie
AU - Destro, Christina
AU - Pavese, Nicola
AU - Garrido, Alicia
AU - Mollenhauer, Brit
AU - Chowdhury, Sohini
AU - Marek, Kenneth
AU - Tanner, Caroline M.
AU - Tropea, Thomas F.
AU - Marek, Kenneth
AU - Simuni, Tanya
AU - Siderowf, Andrew
AU - Tanner, Caroline
AU - Tropea, Thomas F.
AU - Foroud, Tatiana
AU - Chahine, Lana
AU - Mollenhauer, Brit
AU - Merchant, Kalpana
AU - Galasko, Douglas
AU - Coffey, Christopher
AU - Poston, Kathleen
AU - Dobkin, Roseanne
AU - Brown, Ethan
AU - Alcalay, Roy
AU - Weintraub, Dan
AU - Flagg, Emily
AU - Fabrizio, Kimberly
AU - Bressman, Susan
AU - Blauwendraat, Cornelis
AU - Casalin, Paola
AU - Dumanis, Sonya
AU - James, Raymond
AU - Kieburtz, Karl
AU - Mantri, Sneha
AU - Poewe, Werner
AU - Schwarzschild, Michael
AU - Seibyl, John
AU - Standaert, David
AU - Tosun-Turgut, Duygu
AU - Leaver, Katherine
N1 - Publisher Copyright:
© 2026 American Neurological Association.
PY - 2026
Y1 - 2026
N2 - In the 15 years since Parkinson's Progression Markers Initiative (PPMI) launched, research conduct has advanced with broader connectivity, enabling virtual and hybrid methods for recruitment, engagement, education, and data collection. To meet evolving needs, PPMI created “myPPMI,” which has grown from an informational portal to a multi-country, participant-centered, virtual research environment integrating education, screening, e-consent, longitudinal non-motor and motor assessments, and biospecimen referral. Built on a secure, cloud-native architecture with daily analytics and a multi-tier support model, myPPMI enables precision recruitment, real-time eligibility matching, and standardized low-burden data capture across studies. The platform is designed to enable focused data collection from individuals or groups based on the data they have already provided. This strategy provides the tools to establish precise subsets of high interest that could be targeted for further data acquisition. Usability testing and rapid global scaling demonstrate a generalizable, decentralized framework for biomarker-driven, Parkinson's disease research. ANN NEUROL 2026.
AB - In the 15 years since Parkinson's Progression Markers Initiative (PPMI) launched, research conduct has advanced with broader connectivity, enabling virtual and hybrid methods for recruitment, engagement, education, and data collection. To meet evolving needs, PPMI created “myPPMI,” which has grown from an informational portal to a multi-country, participant-centered, virtual research environment integrating education, screening, e-consent, longitudinal non-motor and motor assessments, and biospecimen referral. Built on a secure, cloud-native architecture with daily analytics and a multi-tier support model, myPPMI enables precision recruitment, real-time eligibility matching, and standardized low-burden data capture across studies. The platform is designed to enable focused data collection from individuals or groups based on the data they have already provided. This strategy provides the tools to establish precise subsets of high interest that could be targeted for further data acquisition. Usability testing and rapid global scaling demonstrate a generalizable, decentralized framework for biomarker-driven, Parkinson's disease research. ANN NEUROL 2026.
UR - https://www.scopus.com/pages/publications/105036721667
U2 - 10.1002/ana.78230
DO - 10.1002/ana.78230
M3 - Editorial
C2 - 42015362
AN - SCOPUS:105036721667
SN - 0364-5134
JO - Annals of Neurology
JF - Annals of Neurology
ER -